Clinical trial
Comparison of Intravenous Magnesium Sulphate and Lignocaine in Attenuation of Hemodynamic Responses to Laryngoscopy and Endotracheal Intubation
NCT07793955 is registered in ClinicalTrials.gov with Lady Reading Hospital, Pakistan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Intravenous Magnesium Sulphate and Lignocaine in Attenuation of Hemodynamic Responses to Laryngoscopy and Endotracheal Intubation
- Lead sponsor
- Lady Reading Hospital, Pakistan
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 20, 2026
- Completion date
- September 20, 2026
- Enrollment
- 78 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic response to laryngoscopy and tracheal intubation